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Chromosomally mediated penicillin resistance in Neisseria gonorrhoeae occurs in part through alterations in
penicillin-binding proteins (PBPs) and a decrease in outer membrane permeability. However, the genetic and
molecular mechanisms of transformation of a penicillin-susceptible strain of N. gonorrhoeae to high-level
penicillin resistance have not been clearly elucidated. Previous studies suggested that alterations in PBP 1 were
involved in high-level penicillin resistance. In this study, we identified a single amino acid mutation in PBP 1
located 40 amino acids N terminal to the active-site serine residue that was present in all chromosomally
mediated resistant N. gonorrhoeae (CMRNG) strains for which MICs of penicillin were >1 g/ml. PBP 1
harboring this point mutation (PBP 1*) had a three- to fourfold lower rate of acylation (k2/K) than wild-type
PBP 1 with a variety of -lactam antibiotics. Consistent with its involvement in high-level penicillin resistance,
replacement of the altered ponA gene (ponA1) in several CMRNG strains with the wild-type ponA gene resulted
in a twofold decrease in the MICs of penicillin. Surprisingly, transformation of an intermediate-level penicillin-
resistant strain (PR100; FA19 penA4 mtr penB5) with the ponA1 gene did not increase the MIC of penicillin for
this strain. However, we identified an additional resistance locus, termed penC, which was required along with
ponA1 to increase penicillin resistance of PR100 to a high level (MIC  4 g/ml). The penC locus by itself, when
present in PR100, increases the MICs of penicillin and tetracycline twofold each. These data indicate that an
additional locus, penC, is required along with ponA1 to achieve high-level penicillin resistance.
Up until 1987, Neisseria gonorrhoeae was treated with a sin-
gle dose of penicillin, which kills the bacteria by inhibiting the
penicillin-binding proteins, or PBPs, that synthesize the cell
wall peptidoglycan. N. gonorrhoeae has four PBPs, designated
PBP 1, 2, 3, and 4 (1; P. A. Ropp and R. A. Nicholas, unpub-
lished data.). Of these, only PBPs 1 and 2 are essential for cell
viability and thus are potential antibiotic killing targets in N.
gonorrhoeae. Because penicillin G has an approximately 10-
fold higher rate of acylation with PBP 2 than with PBP 1,
penicillin G kills N. gonorrhoeae at its MIC by inactivation of
PBP 2 (1).
While early isolates of N. gonorrhoeae were extremely sen-
sitive to penicillin (MICs  0.004 to 0.01 g/ml), this sensitivity
gradually decreased such that by the late 1970s strains emerged
that were resistant to penicillin (MICs  2 g/ml). Resistance
to other antibiotics, including tetracycline and erythromycin,
also increased during this time. Penicillin resistance in the
gonococci arose by two independent mechanisms: the plasmid-
mediated production of a penicillinase (TEM-1 -lactamase)
and the chromosomally mediated expression of multiple resis-
tance genes. In 1998, 29.4% of the clinical gonococcal isolates
collected throughout the United States by the Gonococcal
Isolate Surveillance Project overseen by the Centers for Dis-
ease Control and Prevention (CDC) were resistant to either
penicillin, tetracycline, or both (6). While the percentage of
penicillinase-producing N. gonorrhoeae organisms (PPNG) de-
clined significantly during the years 1991 to 1998, the percent-
age of chromosomally mediated resistant N. gonorrhoeae or-
ganisms (CMRNG) rose.
The genetic mechanisms of chromosomally mediated resis-
tance to penicillin have been investigated in some detail (8,
11). Because N. gonorrhoeae is naturally transformable, peni-
cillin-resistant strains are capable of transferring their resis-
tance genes to susceptible strains in a stepwise manner via
transformation and homologous recombination (Fig. 1). The
first step in transformation to high-level penicillin resistance
(MIC  2 g/ml) is mediated by the penA gene, which encodes
altered forms of PBP 2 that display 5- to 10-fold decreases in
their rate of acylation by penicillin (28). The second step of
transformation is mediated by the mtr locus, which confers
nonspecific resistance to erythromycin, rifampin, and deter-
gents through increased expression of the MtrC-MtrD-MtrE
efflux pump (17). Transfer of the penB locus leads to further
increases in both penicillin and tetracycline resistance (5). Re-
cently, the penB phenotype has been correlated to mutations in
the porin P1B allele that presumably decrease the porin-me-
diated flux of antibiotics across the outer membrane (15).
Unexpectedly, transformation of a penA mtr penB strain (for
which the MIC of penicillin is 0.5 to 1.0 g/ml) to a level of
penicillin resistance equal to that of the donor strain (MIC 
4 g/ml) has been difficult to achieve in the laboratory (8, 11).
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Because penicillin-resistant strains for which MICs are 2
g/ml appear to express an altered form of PBP 1 that displays
a lower rate of acylation by penicillin, the PBP 1 gene likely is
involved in transformation to high-level penicillin resistance
(7). Dougherty was able to obtain high-level penicillin-resistant
transformants at low frequency by using a modified transfor-
mation procedure and by selecting transformants at penicillin
concentrations two- to fourfold less than the MIC for the
FIG. 1. Stepwise acquisition of resistance genes in gonococci by DNA uptake and homologous recombination. The stepwise transfer of
resistance genes occurs in the order shown, and each step increases resistance to at least one of the three antibiotics shown on the right. The first
three resistance genes (penA, mtr, and penB) are well characterized, and transformants with these genes are easy to obtain in the laboratory. In
contrast, transformation of an FA19 penA mtr penB strain up to a level of resistance equal to that of the donor strain has been very hard to achieve
in the laboratory. The last two steps of transformation to high-level resistance (in blue) are mediated by two resistance loci, penC and ponA1, that
are the subjects of this study.
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donor strain (7). Assessment of the binding of [3H]penicillin G
to membranes prepared from these transformants revealed an
apparent heterogeneity in the affinity of PBP 1 for penicillin.
One group expressed a PBP 1 with an affinity for penicillin G
equal to that of the donor strain, whereas another group ex-
pressed a PBP 1 with an intermediate affinity. These results
suggested that PBP 1 plays a role in mediating high-level pen-
icillin resistance in CMRNG.
We recently cloned the ponA gene encoding PBP 1 from a
penicillin-susceptible strain of N. gonorrhoeae (24). In the
present study, we isolated and sequenced the ponA gene from
several clinical isolates of N. gonorrhoeae for which penicillin
MICs were 1 g/ml in order to determine the changes in the
amino acid sequence that presumably lead to a decreased rate
of acylation by penicillin. In addition, we investigated the role
of the altered ponA gene in mediating transformation of inter-
mediate-level penicillin-resistant transformants to high-level
penicillin resistance. Our results indicate that both the
ponA1 gene encoding an altered form of PBP 1 and another
resistance locus, termed penC, are required to achieve high-
level chromosomally mediated penicillin resistance.
MATERIALS AND METHODS
Bacterial strains and plasmids. Clinical isolates of N. gonorrhoeae for which
penicillin G MICs were 1 g/ml were obtained from several sources. Strains
2227, 0387, 3391, 5611, and 9634 were kindly provided by Marcia Hobbs and
Myron S. Cohen, University of North Carolina at Chapel Hill, from a Wilson
county (North Carolina) surveillance program (12). FA19 (21) and FA6140 (for
which the penicillin MIC was 4 g/ml) (5) were obtained from Fred Sparling,
University of North Carolina at Chapel Hill. Piliated FA6140 was obtained from
William Shafer, Emory University. Strains 111, 114, 131, 151, and 154 were
obtained from Joan Knapp at the CDC. Chromosomal DNA from CMRNG
strains CDC77-124615 (8) and CDC84-060418 (7) was kindly provided by Brian
Spratt, Imperial College, London.
The plasmids pPR16 and pPR17 harbor the coding regions of the wild-type
and mutant ponA genes, respectively, with an extra 546 bp of downstream
sequence to facilitate homologous recombination. To aid in selection, each
plasmid also contained the  fragment encoding spectinomycin and streptomy-
cin resistance (23), inserted 68 bp downstream of the ponA stop codon (see Fig.
2). pMutS-erm, which contained the gonococcal mutS gene inactivated by inser-
tion of an erythromycin resistance cassette, was provided by Janne Cannon,
University of North Carolina at Chapel Hill.
Media, growth conditions, and MIC determinations. N. gonorrhoeae strains
were grown on GC medium base (GCB) agar (Difco Laboratories, Detroit,
Mich.) with supplements I and II (20) at 37°C in 5% CO2. Liquid cultures were
grown in GCB broth containing supplements I and II, supplement B, and 10 mM
NaHCO3 in a shaking incubator at 37°C. MICs were determined according to the
method of Sparling et al. (27) or by the spot method. Briefly, cells were resus-
pended in GCB broth, and 1,000 colonies were spread onto GCB agar plates
containing increasing concentrations of the appropriate antibiotic. The MIC was
defined as the minimal concentration of antibiotic at which no more than five
colonies were observed after 24 h. Alternatively, colonies were suspended in
GCB broth and 5  104 colonies in 5 l were spotted onto GCB agar plates
containing increasing twofold concentrations of the antibiotic. The MIC was
defined as the minimal concentration of antibiotic that inhibited growth after
24 h. The two methods gave very similar results.
General methods. Chromosomal DNA was isolated by ethidium bromide-CsCl
equilibrium centrifugation by a modification of the method of Dowson et al. (10).
In some instances, chromosomal DNA was isolated with the DNAzol reagent
(Gibco/BRL, Gaithersburg, Md.) following the manufacturer’s instructions.
p-Trimethylstannyl-penicillin V (a gift from Larry Blaszczak; Eli Lilly and Co.)
was converted to [125I]iodopenicillin ([125I]IPV) as described previously (2).
Protein concentrations were determined by Bradford assay (Bio-Rad, Hercules,
Calif.).
Isolation and sequencing of the ponA gene from penicillin-resistant strains.
The ponA1 gene was cloned initially from FA6140. The complete coding region
of the ponA gene was amplified by PCR from FA6140 DNA with primers GC23
(5-GTGAGTAACCGTTTCGGTATCC-3), which hybridizes 124 bp upstream
of the ATG start codon, and GC44 (5-TTAAAACAGGGAATCCAACTGC-
3), an antisense oligonucleotide that hybridizes to the last 22 bp of the ponA
gene. The amplified product was subcloned into pUC19-K (pUC19 containing
the kanamycin resistance gene). Both strands of the plasmid harboring the ponA
gene as well as the ponA PCR product were sequenced with the Amplicycle CS
sequencing kit (Perkin-Elmer, Foster City, Calif.). The same sequence was ob-
tained from multiple independent amplifications, verifying that the mutation was
not a PCR artifact. Sequences of the ponA genes from the other penicillin-
resistant strains examined in this study were amplified by PCR and sequenced
directly as described above.
Genetic transformation. N. gonorrhoeae was transformed as described previ-
ously (25). Briefly, cells were passaged on GCB agar, and a single piliated colony
was streaked onto a fresh GCB plate and allowed to grow overnight. Cells were
scraped from the plate and gently resuspended in prewarmed GCB broth con-
taining supplements I and II and 10 mM MgCl2. Resuspended cells were diluted
in prewarmed GCB broth to a cell density of 108/ml (optical density at 560 nm,
0.18), followed by the addition of NaHCO3 to a final concentration of 10 mM.
Aliquots (900 l) of diluted cells were mixed gently with 100 l of 20-g/ml
donor DNA (either plasmid or chromosomal DNA) and allowed to incubate for
5 h at 37°C in a humidified 5% CO2 atmosphere. Various amounts of cells were
then plated onto GCB agar containing the appropriate antibiotic concentrations
(described below) and grown 24 to 48 h at 37°C in 5% CO2.
PR100 (FA19 penA4 mtrR penB5; see Table 3) was constructed by transform-
ing FA19 with FA6140 genomic DNA and selecting for each resistance gene at
the following antibiotic concentrations: (i) penA4, 0.16 g of penicillin G per ml;
(ii) mtr, 0.5 g of erythromycin per ml; and (iii) penB5, 0.37 g of tetracycline per
ml. Each of these genes was amplified by PCR from PR100 genomic DNA and
sequenced; all three genes corresponded exactly to the sequences obtained from
FA6140. Other transformants were selected on GCB agar containing antibiotic
concentrations as indicated. Gonococci transformed with pPR16 or pPR17 plas-
mid DNA harboring the  fragment were selected on GCB agar containing 100
g of spectinomycin per ml, whereas cells transformed with plasmid constructs
containing the erythromycin resistance gene (i.e., for disruption of mutS) were
selected on 10 g of erythromycin per ml. Since pUC plasmids are not replicative
in N. gonorrhoeae, transformation occurred via homologous recombination into
the genome. To test for the presence of the ponA1 mutation in transformation
experiments, individual colonies were resuspended in 100 l of 10 mM Tris-
HCl–1 mM EDTA, pH 8.0, placed in a boiling water bath for 10 min, and then
centrifuged. The ponA gene was then amplified from 1 l of the boiled lysates
with the following primers: 5-CGCGGTGCGGAAAACTGATATCGAT-3 (bp
955 to 978 of ponA open reading frame) and 5-AGCCCGGATCGGTTACCA
TACGTT-3 (bp 2218 to 2195 of ponA open reading frame). Aliquots (5 l) of
the amplification reaction mixture were used for subsequent PstI digestion with-
out further purification.
To examine if the increased resistance in penC strains was due to an additional
mutation(s) in one of the genes comprising the mtr operon, we amplified the
mtrR  mtrC, mtrD, mtrE, and mtrF genes from the mtr operon by PCR from 1 ng
of PR102 DNA and tested the ability of each fragment to transform PR100
to PR100 penC. The primers were designed such that each amplified fragment
contained at least one uptake sequence. Following amplification, the fragments
were purified from an agarose gel and mixed with piliated PR100 cells, and
resistant transformants were selected on GCB plates containing 0.95 g of
penicillin per ml. As a positive control, the mtrR  mtrC fragment (which
contains the original mtr mutation) was used to transform FA19 penA4 to FA19
penA4 mtr (transformation frequency, 3  10	5).
Purification of recombinant PBP 1 and PBP 1*. The coding sequences of the
ponA genes from both FA19 and FA6140 were amplified by PCR with Taq DNA
polymerase (Gibco/BRL), cloned into pET15b-K (pET15b containing the kana-
mycin resistance gene in place of the -lactamase gene), and transformed into
Escherichia coli BL21(DE3) as previously described (24). These constructs result
in the fusion of 20 additional amino acids, including a hexahistidine tag, to the
amino termini of PBP 1 and PBP 1* (PBP 1 containing the Leu-4213Pro mu-
tation).
E. coli BL21(DE3) cells containing PBP 1 expression plasmids were grown in
Luria-Bertani medium supplemented with kanamycin (50 g/ml). Overnight
growth resulted in significant expression of PBP 1 in the absence of induction.
Cells were pelleted, resuspended in cold lysis buffer (50 mM sodium phosphate
buffer [pH 8.0], 10% glycerol, 0.5 mM phenylmethylsulfonyl chloride), and lysed
by three passes through an Aminco French pressure cell (Champaign, Ill.) at
16,000 lb/in2. Membranes were isolated from the cell lysate by centrifugation at
225,000  g, washed, resuspended, and stored at 	20°C. Crude membranes were
solubilized with an equal volume of 50 mM sodium phosphate buffer (pH 8.0)–
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2 M NaCl–2% Triton X-100–40 mM imidazole for 1 h with stirring at room
temperature.
Following centrifugation at 225,000  g, the supernatants containing solubi-
lized PBP 1 or PBP 1* were loaded directly onto Ni2-NTA columns (Qiagen,
Chatsworth, Calif.) and washed with 50 mM sodium phosphate (pH 8.0)–1 M
NaCl–10% glycerol–0.1% Triton X-100–15 mM imidazole. PBP 1 and PBP 1*
were eluted with an increasing linear gradient of imidazole (15 to 500 mM) in the
above buffer. Fractions containing PBP 1 or PBP 1* were pooled, concentrated
by ultrafiltration, and then dialyzed extensively against 50 mM sodium phosphate
(pH 8.0)–0.5 M NaCl–10% glycerol–0.1% Triton X-100 to remove imidazole.
The purified proteins were stored at 	80°C at a concentration of 2 to 4 mg/ml.
Determination of the kinetic constants for the interaction of -lactam anti-
biotics with PBP 1 and PBP 1*. k2/K constants of recombinant PBP 1 and
PBP 1* for [125I]IPV were determined from time courses of acyl-enzyme forma-
tion as described by Frere et al. (14). Briefly, purified proteins were incubated at
30°C with [125I]IPV concentrations ranging from 0.625 to 5 mM in 50 mM
sodium phosphate–1 mM EDTA–0.1% Triton X-100 (pH 7.4), and the reaction
was stopped by the addition of sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis sample buffer at 0.5- to 1-min time intervals. The samples were run
on a sodium dodecyl sulfate–8% polyacrylamide gel, and the dried gel was
exposed to a phosphorimaging screen for 12 to 24 h. Levels of acyl-enzyme
formed were quantitated with ImageQuant software following imaging on a
Storm 840 Phosphorimager (Molecular Dynamics, Sunnyvale, Calif.). The k2/K
constants was derived from the slope of a plot of the apparent first-order rate
constant ka versus the concentration of [125I]IPV. The k2/K values for penicillin,
ceftriaxone, and cephaloridine were determined by the competition method as
described previously (14).
k3 values were determined by monitoring the formation of free PBP from
samples of PBP-antibiotic complexes. PBPs were incubated with unlabeled an-
tibiotics for 15 min at 30°C, and excess antibiotics were removed by dialysis at 4°C
against the same buffer as above with the addition of 10% glycerol. The addition
of glycerol was necessary to ensure the stability and activity of PBP 1 proteins
during prolonged incubations. Following dialysis, the protein complex was incu-
bated at 30°C, aliquots were removed at various times, and the amount of free
PBP was assessed by incubation with a saturating concentration of [125I]IPV. The
relative amounts of labeled PBPs were derived by phosphorimager analysis as
described above. No significant hydrolysis was observed over 3 days of incuba-
tion.
RESULTS
Identification of an altered form of the ponA gene from
CMRNG strains. Previous studies have shown that high-level
penicillin resistance in N. gonorrhoeae is correlated with ex-
pression of PBP 1 displaying an apparent decrease in its affinity
for penicillin (7, 8). These data suggested that one or more
mutations were present in the primary sequence of PBP 1 that
decreased its rate of acylation with penicillin. To test this
hypothesis, we isolated the ponA gene from the high-level
penicillin-resistant strain FA6140 (5) (penicillin MIC  4 g/
ml) by PCR amplification of genomic DNA and compared its
nucleotide sequence to that of the ponA gene from the peni-
cillin-susceptible strain FA19 (24). Sequence analyses of sev-
eral independent clones isolated from separate amplification
reactions identified a single point mutation, a T-to-C transi-
tion, at nucleotide 1261 of the ponA coding region (hereafter
designated ponA1) (Fig. 2A). This mutation, which results in
the change of Leu-4213Pro, was the only difference observed
in the entire 2,400-bp coding region.
To determine if this mutation occurs in the ponA gene from
other penicillin-resistant strains, the ponA genes from 10 geo-
graphically and temporally distinct CMRNG isolates for which
penicillin MICs were 1 g/ml were amplified and sequenced.
Serovars of these strains suggest that these strains were de-
scended from different lineages (Table 1). Nine of these strains
harbored the ponA1 gene containing a point mutation identical
to that observed in the ponA gene from FA6140 (Table 1). Two
of these strains, CDC120177 and FA6140, were isolated in the
late 1970s; strains 111, 114, and 131 were isolated in Cincin-
nati, Ohio, in 1994; and strains 0387, 3391, 5611, and 9634 were
isolated in rural North Carolina in 1993 from a gonococcal
FIG. 2. Location of the Leu-4213Pro mutation in PBP 1*. (A) The
ponA gene is shown along with the locations of the two functional
domains, the transglycosylase domain and the transpeptidase domain.
Locations of the three highly conserved sequence motifs found in all
penicillin-interacting proteins are shown above the transpeptidase do-
main. The location of the Leu-4213Pro mutation is shown by an
asterisk. Also shown are the DNA sequences of the ponA and ponA1
genes. The mutation fortuitously disrupts a unique PstI restriction site.
(B) Schematic showing the construct (pPR17) used to create the
strains containing the ponA1 gene. The  fragment, which encodes
resistance to both spectinomycin and streptomycin, was used to iden-
tify transformants containing the ponA1 mutation (see text for details).
pPR16 is identical to pPR17, except that it contains the wild-type ponA
gene.
TABLE 1. Characteristics of the N. gonorrhoeae
strains used in this study
Straina MIC(g/ml)
Codon-421 in
the ponA gene Serovar
Reference
or source
FA19 0.016 CTG A10 21
0387 2 CCG B3 12
3391 1 CCG B2 12
5611 1 CCG B3 12
9634 1 CCG B2 12
111 4 CCG B3 CDC
114 4 CCG B3 CDC
131 4 CCG B3 CDC
FA6140 4 CCG B1 5
CDC77-124615 2b CCG B4 8
CDC84-060418 1b CTG B2 7
a Gonococcal isolates (with the exception of CDC77-124615 and CDC84-
060418) were obtained from the indicated sources, and the MICs of penicillin for
these strains were determined as described in Materials and Methods. Serovars
of CDC77-124615 and CDC84-060418 were determined from the sequences of
their porin genes (19).
b Only genomic DNA was available from these strains.
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surveillance program. As we observed with the ponA1 gene
from FA6140, there were no other differences in the ponA
genes from these other strains. CDC84-060418, the only strain
that did not contain the mutation, is known to be different from
the majority of CMRNG strains in that it expresses an altered
PBP 2 with an extremely low rate of acylation by penicillin, but
with little to no change in the rate of acylation of PBP 1 (7).
Thus, with the exception of CDC84-060418, all CMRNG
strains for which the MIC of penicillin was 1 g/ml showed
the presence of the altered codon in the ponA gene.
Interaction of PBP 1 and PBP 1* with -lactam antibiotics.
The T-to-C transition in the ponA1 gene results in a change of
Leu-4213Pro in the PBP 1 amino acid sequence (hereafter
referred to as PBP 1*; Fig. 2A). Leu-421 is 40 amino acids to
the amino-terminal side of the active-site serine residue (Ser-
461) and thus is near (but not necessarily within) the active-site
cavity. To assess the functional consequences of the Leu-
4213Pro amino acid mutation in PBP 1*, both the wild-type
and mutant forms of PBP 1 were expressed in E. coli and
purified, and the kinetic constants for their interaction with
-lactam antibiotics were determined. -Lactam antibiotics in-









where E is the enzyme, S is a -lactam antibiotic, and P is the
inactive degradation product (13, 22). The effectiveness of an
antibiotic is defined by two parameters: (i) the second-order
specificity constant, k2/K, where K  k	1/k1; and (ii) the
rate constant for hydrolysis of the acyl-enzyme complex, k3.
The Leu-4213Pro mutation results in a fourfold decrease in
the k2/K constant for [
125I]IPV and approximately three- to
fourfold decreases in the k2/K constants for penicillin G,
ceftriaxone, and cephaloridine (Table 2). No changes in the
rates of hydrolysis of the acyl-enzyme complex were observed,
indicating that resistance arises from a lower rate of acylation
by -lactam antibiotics and not by an increase in the rate of
deacylation.
Role of the ponA1 gene in transformation of an intermedi-
ate-level resistant strain to high-level penicillin resistance.
The identification of a mutation in PBP 1 that decreases its
rate of acylation with -lactam antibiotics suggests that the
ponA1 gene is involved in conferring high-level penicillin re-
sistance. To determine the role of PBP 1* in resistance, we first
produced an intermediate-level penicillin-resistant strain
(PR100; FA19 penA4 mtr penB5) as described in Materials and
Methods. PCR amplification and sequencing of the penA4, mtr,
and penB5 genes from PR100 verified that these genes were
identical to those in FA6140 (data not shown). For PR100,
both penicillin and tetracycline have a MIC of 1.0 g/ml, and
this strain also shows increased resistance (relative to FA19) to
both ceftriaxone and cephaloridine (Table 3).
PR100 was transformed with the plasmid pPR17, which con-
tains the entire ponA1 gene and 546 bp of the 3 flanking
sequence with the  fragment (encoding spectinomycin resis-
tance) (23) inserted 68 bp downstream of the ponA1 stop
codon (Fig. 2B). The transformed cells were plated on GCB
plates containing either 2 g of penicillin per ml or 100 g of
spectinomycin per ml. No colonies grew on the GCB-penicillin
plates, even though spectinomycin-resistant colonies were iso-
TABLE 2. Kinetic constantsa of PBP 1 and PBP 1* for
interaction with -lactam antibiotics
Antibiotic
PBP 1 PBP 1*
k2/K (M	1s	1) k3 (s	1) k2/K (M	1s	1) k3 (s	1)
[125I]IPV 1,171 
 425 10	5 293 
 143 10	5
Penicillin G 4,036 
 1,316 10	5 1,156 
 200 10	5
Ceftriaxone 20,649 
 2,476 10	5 7,048 
 1,512 10	5
Cephaloradine 217 
 39 10	5 66 
 16 10	5
a k2/K values of the purified PBPs for [125I]IPV were derived from the slopes
of the apparent rate constant, ka, for formation of the acyl-enzyme complex
versus concentration of [125I]IPV, while the k2/K values for the other antibiotics
were obtained from the competition of [125I]IPV binding as described in Mate-
rials and Methods. k3 values were obtained either by quantitating the loss of
radioactivity from the protein over time ([125I]IPV) or by quantitating the gain of
[125I]IPV binding over time (all other antibiotics).







PenG Tet Erm Ceftr Ceph
FA19 Wild-type, antibiotic-susceptible
isolate
0.016 0.15 0.5 0.0006 2
FA19 ponA1 FA19 ponA1b FA19 pPR17 Spectinomycin (100) 0.016 0.15 0.5 ND ND
FA19 penA4 First-level penicillin-resistant
transformant
FA19 FA6140 PenG (0.016) 0.128 0.15 ND ND ND
FA19 penA4 ponA1 FA19 penA4 ponA1 FA19 penA4 pPR17 Spectinomycin (100) 0.128 0.15 ND ND ND
PR100 FA19 penA4 mtrR penB5 FA19 FA6140 –c 1.0 1.0 4.0 0.01 8
PR101 PR100 ponA1 PR100 pPR17 Spectinomycin (100) 1.0 1.0 4.0 ND ND
PR102 PR100 penC PR100 PenG (0.95) 2.0 2.0 4.0 0.04 12
PR103 PR100 mutS::ermd PR100 pMutS-erm Erythromycin (10) ND ND ND ND ND
PR105 PR100 penC ponA1 PR102 pPR17 Spectinomycin (100) 4.0 2.0 4.0 0.04 24
FA6140 High-level penicillin-resistant
clinical isolate
4.0 4.0 4.0 0.08 24
FA6140 ponA-wt FA6140 ponAWT FA6140 pPR16 Spectinomycin (100) 2.0 4.0 ND ND ND
a PenG, penicillin G; Tet, tetracycline; Erm, erythromycin; Ceftr, ceftriaxone; Ceph, cephaloridine; ND, not determined.
b The linked spectinomycin-streptomycin resistance gene () is located 40 bp downstream of the ponA1 stop codon (Fig. 2B).
c Construction of PR100 is described in Materials and Methods.
d The mutS gene was disrupted by insertion of the erythromycin resistance gene.
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lated at a frequency of 10	5. We screened the spectinomycin-
resistant transformants for the successful recombination of the
linked ponA1 mutation by PCR amplification of the ponA gene
and subsequent digestion of the PCR products with PstI. For-
tuitously, the ponA1 mutation destroys a unique PstI site within
the ponA gene, and thus loss of the PstI site in the amplified
fragments is diagnostic for the presence of ponA1 (Fig. 2A).
Approximately half of the spectinomycin-resistant colonies had
incorporated the ponA1 mutation (data not shown). Surpris-
ingly, there was no increase in the MIC of penicillin for spec-
tinomycin-resistant transformants containing the ponA1 muta-
tion (PR101; Table 3). Thus, acquisition of the ponA1 gene by
an intermediate-level penicillin-resistant strain does not in-
crease the MIC of penicillin to the level seen with FA6140.
To determine whether PBP 1* is involved in high-level
penicillin resistance at all, we replaced the ponA1 gene in
FA6140 with the wild-type ponA gene and determined the
MIC of penicillin for the resulting isogenic strain. FA6140
was transformed with pPR16, a plasmid containing the wild-
type ponA gene and the linked  fragment, and spectino-
mycin-resistant colonies were screened for the presence of
the wild-type gene by PstI digestion of the amplified ponA
gene. For several such transformants, designated FA6140
ponA-wt, consistent twofold decreases in the MIC of peni-
cillin (2 g/ml; Table 3) were observed, indicating that the
ponA1 gene is involved in high-level penicillin resistance in
FA6140. The MIC of tetracycline was unchanged. Identical
results were obtained with the CMRNG strains 111, 114, and
131.
Identification of penC, a previously uncharacterized resis-
tance gene. In our attempts to obtain penicillin-resistant colo-
nies following transformation of PR100 with either pPR17
plasmid DNA or FA6140 chromosomal DNA, we observed the
growth of a few (5 to 25) colonies following plating on GCB
plates containing 0.95 g of penicillin per ml. For all of these
colonies, twofold increases in the MICs of both penicillin (2.0
g/ml) and tetracycline (2.0 g/ml) and similar increases in the
MICs of ceftriaxone and cephaloridine (Table 3) were ob-
served. PCR amplification of the ponA gene and digestion with
PstI showed that none of these colonies had recombined the
ponA1 gene (data not shown), which was consistent with our
previous data showing that the ponA1 gene does not increase
the MIC of penicillin when transformed into PR100. More-
over, we were able to isolate penicillin- and tetracycline-resis-
tant colonies for which the MICs showed twofold increases
simply by plating PR100 (FA19 penA mtr penB) on GCB-
penicillin or GCB-tetracycline plates (i.e., in the absence of
DNA transformation). The increase in MICs observed with
these colonies (designated PR102; Table 3) was stable to re-
peated passages on GCB agar over several days with no anti-
biotics present, strongly suggesting that resistance was due to a
genetic event and not to an induction of an enzyme in response
to antibiotic challenge.
These data suggest that the twofold increase in penicillin
and tetracycline resistance is due to a low-frequency, sponta-
neous mutation within the population of PR100. If true, then
plating PR100 containing a disrupted mutS gene (which in-
creases mutation frequency) on selective media should result
in a large increase in the numbers of penicillin- and tetracy-
cline-resistant colonies. Consistent with this hypothesis, plating
PR103 (PR100 mutS) on selective media produced colonies at
a frequency 17-fold higher on average than for PR100 (n  3;
data not shown). Moreover, the MICs of both penicillin and
tetracycline for all of the resistant colonies derived from
PR103 increased twofold. This experiment provides additional
evidence that the increased resistance is due to a spontane-
ously arising genetic mutation in an as yet unidentified locus.
This locus has been designated penC.
Repeated attempts to transform PR100 to PR100 penC with
DNA from the CMRNG strains FA6140, 114, and 131 were
unsuccessful. However, we were able to transform penC into
PR100 with chromosomal DNA isolated from PR102 (PR100
penC; Table 3) at a frequency of 10	5. (While this transfor-
mation frequency is lower than that obtained when penA4 is
transformed into FA19 [3  10	4], similar transformation
frequencies were obtained when PR100 was transformed with
either plasmid or chromosomal DNA containing different re-
sistance markers. These results suggest that the lower trans-
formation frequency of PR100 is a characteristic of the strain
and is not related to the penC locus.) The inability to transform
the penC locus into PR100 from FA6140, 114, and 131 indi-
cates that these CMRNG strains do not contain the penC locus
and suggests that a novel mechanism or another as yet uniden-
tified mutation is involved in high-level penicillin resistance in
these strains. However, given that penC can arise spontane-
ously, we suspect that the penC locus will be found in other
CMRNG strains when a more extensive search is conducted.
Since both ponA1 and penC are required to mediate high-
level penicillin resistance in FA19, we attempted to identify a
similar resistance locus in FA6140 by transforming PR101
(PR100 ponA1) with FA6140 DNA to high-level penicillin re-
sistance. However, these attempts were unsuccessful, suggest-
ing that in FA6140 an additional resistance locus that is not
easily transformable or a novel genetic mechanism is involved
in high-level resistance.
The penC locus does not encode additional mutations in
previously characterized resistance genes. We also considered
the possibility that additional mutations in the three known
resistance loci (penA, mtr, and penB) might underlie the in-
creased resistance observed in penC strains. To test this pos-
sibility, we sequenced the penA and penB genes from both
PR100 and PR102 (PR100 penC). No differences were noted in
either gene obtained from the two strains. To determine if
mutation(s) in one or more of the genes encoding the Mtr
efflux pump might be responsible for the increased resistance
observed in penC strains, we amplified the mtrR  mtrC, mtrD,
mtrE, and mtrF genes from PR102 by PCR and used these
fragments in an attempt to transform PR100 into PR100 penC.
None of the fragments gave rise to penicillin- or tetracycline-
resistant colonies at a frequency higher than that of a no-DNA
control, while DNA from PR102 transformed PR100 into
PR102 with a frequency of 10	5. These data are consistent
with the idea that penC is a novel resistance locus and not an
already-characterized resistance gene that has acquired an ad-
ditional mutation.
Transformation of a penC strain to high-level penicillin re-
sistance with ponA1. Even though acquisition of the ponA1
gene by PR100 by itself did not increase penicillin resistance,
acquisition of penC may be required before the ponA1 gene
can increase penicillin resistance. To test this hypothesis, we
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transformed the penC strain PR102 with pPR17 and screened
spectinomycin-resistant transformants for the presence of the
linked ponA1 gene as described above. For the resulting trans-
formants, designated PR105, the MIC of penicillin was 4 g/
ml, the same as for FA6140 (Table 3). The MIC of cephalori-
dine increased following acquisition of ponA1, whereas no
increases were observed for ceftriaxone and tetracycline. We
were unable to transform PR102 to higher penicillin resistance
with FA6140 chromosomal DNA or pPR17 plasmid DNA by
selecting on GCB-penicillin plates, but this may simply reflect
the difficulty in selecting transformants having such a small
increase in penicillin resistance (7). These data demonstrate
that both ponA1 and penC are necessary to transform an in-
termediate-level resistant recipient strain to high-level penicil-
lin resistance. Moreover, the penC locus must already be
present in order for ponA1 to increase resistance. Thus, in-
creasing the penicillin resistance of FA19 to a high level (MIC
 4 g/ml) requires mutations in five genes or loci (penA, mtr,
penB, penC, and ponA1), including both essential PBPs (Fig.
1).
DISCUSSION
The mechanism by which chromosomally mediated penicil-
lin-resistant strains arise in N. gonorrhoeae is different from
that utilized by most other bacteria. Susceptible strains of N.
gonorrhoeae become resistant to penicillin by acquiring multi-
ple resistance genes in a stepwise fashion. As each gene is
acquired, penicillin resistance increases until treatment failure
occurs. While the genes involved in transforming N. gonor-
rhoeae to an intermediate level of penicillin resistance are well
established, those that mediate high-level resistance have not
been identified. In this study, we show that two loci, the ponA1
gene encoding an altered form of PBP 1 and a newly identified
locus, penC, are required to transform an intermediate-level
penicillin-resistant strain to high-level resistance.
The ponA1 gene encodes PBP 1 containing a single amino
acid mutation, Leu-4213Pro, which decreases the rate of ac-
ylation with -lactam antibiotics three- to fourfold compared
to the wild type. An identical mutation was observed in the
ponA genes from penicillin-resistant strains isolated 17 years
apart, from geographically distinct regions, and with different
serovars. Transformation of an intermediate-level penicillin-
resistant strain with the ponA1 gene increased penicillin resis-
tance only when an additional locus, penC, was already
present. These data demonstrate that a penicillin-susceptible
strain must acquire five resistance genes, penA, mtr, penB,
penC, and ponA1, to reach the level of resistance of a high-
level, chromosomally mediated penicillin-resistant strain such
as FA6140.
The mechanism of the emergence and propagation of the
ponA1 mutation in resistant strains of N. gonorrhoeae is in
marked contrast to that described for the penA gene encoding
PBP 2. PenA is the first resistance gene in the stepwise transfer
of resistance genes from a resistant donor strain to a suscep-
tible recipient strain (11). Analysis of the penA genes from
penicillin-resistant strains of N. gonorrhoeae has shown that the
coding sequences contain blocks of DNA with high sequence
divergence from penA genes of susceptible strains (28). Fur-
ther studies showed that in the closely related Neisseria species
N. meningitidis, the divergent blocks of DNA in altered penA
genes arose by horizontal transfer of resistant penA genes from
commensal strains such as N. flavescens or N. cinerea (3, 29,
30). These alterations lead to multiple amino acid changes in
PBP 2, with the most important change being an amino acid
insertion (Asp-345a) that lowers the rate of acylation of PBP 2
with penicillin four- to fivefold (4, 26).
In contrast to the high sequence divergence observed in
altered forms of PBP 2, alteration of PBP 1 is due to a single
base change in the ponA gene that results in mutation of
Leu-421 to proline. We have sequenced the ponA genes from
at least 10 different CMRNG isolates, and the only difference
within the entire 2,400 bp of coding sequence is at codon 421.
These isolates include one of the original CMRNG isolates
from 1977, CDC77-124615, and resistant strains isolated nearly
20 years later in both Cincinnati and North Carolina. This
mutation evidently arose in N. gonorrhoeae, since the ponA
genes from several Neisseria commensal species show signifi-
cant sequence divergence from the ponA gene of N. gonor-
rhoeae, with overall DNA sequence identities of 88% (N. lac-
tamica; accession no. AF085689), 85% (N. cinerea; AF085340),
and 73% (N. flavescens; AF087677) (Ropp and Nicholas, un-
published). Although it is possible that the mutation arose in
N. meningitidis, whose ponA gene is 100% identical to its gono-
coccal homologue in the region of the mutation (24), it seems
unlikely since high-level penicillin resistance in this species has
not yet been noted.
Substitution of Leu-421 with proline causes a three- to four-
fold decrease in the acylation rate of the protein when assessed
with a variety of antibiotics. One of the most unusual aspects of
this mutation is that the alteration is located on the amino-
terminal side of the active-site serine residue. In other PBPs
whose acylation rates have been altered by amino acid muta-
tions, these mutations occur on the C-terminal side of the
active-site serine residue. For example, mutations in altered
forms of PBP 2 are located near two conserved active-site
sequence motifs, the SXN triad and the KTG triad (28), and a
similar location of alterations is observed in the PBPs from
penicillin-resistant strains of Streptococcus pneumoniae (9, 16,
18). Because no high-resolution crystal structure of a class A
PBP is available, it is not possible at this time to understand at
a molecular level how this mutation causes a decrease in the
rate of acylation. Although it is possible that Leu-421 is near
the active site, mutation to proline may simply impart a struc-
tural perturbation (due to the structural effects of proline) that
is propagated from a distance and disturbs the active-site ar-
chitecture. However, in the absence of structural information
for PBP 1 or one of its homologues, the mechanism by which
the mutation decreases acylation remains highly speculative.
Because the fold decrease in k2/K for each of the antibiotics
tested were very similar, i.e., approximately three- to fourfold,
it appears that the structural alteration is general in nature and
not specific to penicillin. However, a more extensive analysis
with additional antibiotics is necessary to confirm this hypoth-
esis.
The original reports detailing the stepwise transformation of
susceptible strains of N. gonorrhoeae by donor DNA from high-
level penicillin-resistant strains noted that transformation of
recipient strains to a level of penicillin resistance equivalent to
that of the donor strain could not be achieved (8, 11). How-
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ever, Dougherty was able to isolate transformants at low fre-
quency for which the MICs of penicillin were equal to those
observed with the donor strain by using high concentrations of
DNA and a modified transformation protocol and by selecting
at penicillin concentrations fourfold below the MIC (7). Given
the low frequency of transformation, Dougherty concluded
that possibly two genes were involved in high-level penicillin
resistance. Our study confirms and extends this hypothesis. We
have shown that acquisition of ponA1 increases the MIC only
when the penC mutation is present. It is probable that Dough-
erty also isolated colonies containing spontaneous mutations in
penC in his experiments, since well over half of the transfor-
mants isolated were cross resistant to tetracycline, even though
no selection for tetracycline was carried out (7).
Despite multiple attempts, we could not obtain colonies
containing the penC locus (with frequencies greater than those
of no-DNA controls) by transforming PR100 with donor DNA
from several high-level penicillin-resistant strains. Our inability
to obtain penC transformants was not due to penC being a
nontransformable locus, since we were able to transform
PR100 to PR100 penC with PR102 DNA at reasonably high
frequencies (i.e., 10	5). This result indicates that the penC
mutation is not present in the CMRNG isolates that we tested
and suggests that a novel mechanism or perhaps a different
genetic background is responsible for resistance in these
strains. It is interesting that the penicillin MIC for FA6140
ponA-wt is 2 g/ml, twofold higher than that of FA19 contain-
ing the first three resistance genes from FA6140 (PR100; FA19
penA4 mtr penB5). The fact that the MIC for FA6140 ponA-wt
is higher than for PR100 implies that the novel mechanism or
genetic background involved in high-level penicillin resistance
in FA6140 increases the MIC of penicillin above that which
can be accounted for by the penA4, mtr, and penB5 genes. This
scenario is reminiscent of the effects of the penC locus.
Introduction of the ponA1 gene into FA19, FA19 penA4, and
FA19 penA4 mtr penB5 (PR100) had no effect on the MIC of
penicillin (Table 3), indicating that penicillin kills these strains
by inhibition of PBP 2. These data also show that PBP 2
remains the killing target even after its rate of acylation is
markedly reduced by alterations in its coding sequence (i.e.,
penA2). However, PBP 1* clearly has a role in clinically rele-
vant high-level penicillin resistance, since replacing the ponA1
gene with the wild-type gene in FA6140 (Table 3) and three
other CMRNG strains resulted in twofold decreases in the
penicillin MICs for these strains. The fact that introduction of
the ponA1 gene into PR102 (PR100 penC) increases the MIC
of penicillin indicates that the penC gene must in some way
decrease the rate of acylation of PBP 2 such that PBP 1 be-
comes the killing target. A similar argument can be made for
CMRNG strains such as FA6140, although the modifying
gene(s) in these strains is not penC but some other as yet
unknown gene or genetic mechanism. It is tempting to specu-
late that in both cases the membrane surface is altered in such
a way that the rate of acylation of PBP 2 within the cell division
complex is decreased below that of PBP 1, allowing PBP 1* to
increase the MIC of penicillin.
In conclusion, this study is the first to show unequivocally
that PBP 1 is involved in penicillin resistance. However, trans-
formation experiments demonstrate that a decrease in the rate
of acylation of PBP 1 is still not sufficient to impart high-level
penicillin resistance (MIC  2 to 4 g/ml) to an intermediate-
level resistant strain, implicating the involvement of an addi-
tional resistance locus in the transformation of gonococci to
high-level resistance. In our studies, that additional locus is
penC; however, in several clinical isolates, the identity of this
locus is not penC but an as yet unidentified locus. Studies are
in progress to identify the penC locus and to define the mech-
anism by which it increases both penicillin and tetracycline
resistance.
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